{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:14:41Z","timestamp":1790612081662,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Applying Extracorporeal membrane oxygenation (ECMO) to patients with acute fulminant myocarditis (AFM) reduces their mortality. The survival rate is 55.6-71.9% for adult AFM patients, which is lower than that for paediatric patients (63-81%). In our centre, the survival rate of ECMO for adult patients with AFM was 66.7% from January 2003 to 2012. In January 2013, the therapeutic regimen was optimised, and then the survival rate increased to 89.1% by January 2022. This article analyses the reasons for the improved survival rate following the optimisation of treatment protocols.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The data for adult patients with AFM who underwent ECMO for a poor response conventional treatment from January 2003 to January 2022 were reviewed. According to different treatment regimens, the AFM patients were divided into an old and a new regimen group. Univariate and multivariate logistic regression analyses were performed on the data before and after ECMO.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fifty-five patients were enrolled in the age (31.2 \u00b1 11.3), including 24 males. Forty-nine patients were weaned successfully from ECMO [duration: (4.1 \u00b1 1.8) d], all of whom were discharged from the hospital, with a survival rate of 89.1%. Compared with the old regimen group, the new regimen group had a shorter duration of shock to ECMO, a lower proportion of patients receiving extracorporeal cardiopulmonary resuscitation (ECPR), a lower Vasoactive Inotropic Score (VIS), and lower levels of lactic acid, and high-sensitivity troponin T before ECMO (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). Compared with the old regimen group, after ECMO, the new regimen group had lower ECMO flow, lower proportion of left ventricular dilation and lower limb ischemia injury, the duration of ECMO was shorter, and significantly improved the survival rate, the difference was statistically significant (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). The duration of shock to ECMO and VIS before ECMO were independent risk factors for the survival rate (<jats:italic>p<\/jats:italic> &amp;lt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Early ECMO initiation in adult AFM patients with a poor response to conventional therapy and low-flow ECMO to meet metabolic needs can reduce serious complications affecting the prognosis, may be associated with better outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1146570","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T04:53:41Z","timestamp":1678942421000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Optimising the ECMO treatment regimen increases the survival rate for adult patients with acute fulminant myocarditis: A single-centre retrospective cohort study"],"prefix":"10.3389","volume":"10","author":[{"given":"Liusheng","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkai","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaozhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1056\/NEJM200003093421003","article-title":"Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis.","volume":"342","author":"McCarthy","year":"2000","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.7150\/ijms.20618","article-title":"Heart failure and mortality of adult survivors from acute myocarditis requiring intensive care treatment - a nationwide cohort study.","volume":"14","author":"Chang","year":"2017","journal-title":"Int J Med Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1093\/eurheartj\/ehi411","article-title":"Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation.","volume":"26","author":"Asaumi","year":"2005","journal-title":"Eur Heart J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ejcts.2010.12.050","article-title":"Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center\u2019s experience.","volume":"40","author":"Hsu","year":"2011","journal-title":"Eur J Cardiothorac Surg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.transproceed.2015.12.109","article-title":"Heart transplantation under mechanical circulatory support for acute fulminant myocarditis with cardiogenic shock.","volume":"48","author":"Ting","year":"2016","journal-title":"Transplant Proc."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/j.athoracsur.2012.09.036","article-title":"Long-term use of ventricular assist device as a bridge to recovery in acute fulminant myocarditis.","volume":"95","author":"George","year":"2013","journal-title":"Ann Thorac Surg."},{"key":"B7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/ehf2.12291","article-title":"Clinical determinants of successful weaning from extracorporeal membrane oxygenation in patients with fulminant myocarditis.","volume":"5","author":"Matsumoto","year":"2018","journal-title":"ESC Heart Fail."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7110452","article-title":"Associations with the in-hospital survival following extracorporeal membrane oxygenation in adult acute fulminant myocarditis.","volume":"7","author":"Chong","year":"2018","journal-title":"J Clin Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jcrc.2020.03.007","article-title":"Prognostic factors for heart recovery in adult patients with acute fulminant myocarditis and cardiogenic shock supported with extracorporeal membrane oxygenation.","volume":"57","author":"Chou","year":"2020","journal-title":"J Crit Care."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1097\/CCM.0000000000000920","article-title":"Extracorporeal membrane oxygenation for the support of adults with acute myocarditis.","volume":"43","author":"Diddle","year":"2015","journal-title":"Crit Care Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.athoracsur.2015.08.014","article-title":"Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients: a 5-year multi-institutional experience.","volume":"101","author":"Lorusso","year":"2016","journal-title":"Ann Thorac Surg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3345\/cep.2020.00836","article-title":"The use of extracorporeal membrane oxygenation in children with acute fulminant myocarditis.","volume":"64","author":"Heinsar","year":"2021","journal-title":"Clin Exp Pediatr."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002767","article-title":"Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-\u03baB.","volume":"5","author":"Seldin","year":"2016","journal-title":"J Am Heart Assoc."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00134-016-4541-y","article-title":"Venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock post-cardiac arrest.","volume":"42","author":"Pineton de Chambrun","year":"2016","journal-title":"Intensive Care Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.resuscitation.2021.11.015","article-title":"Predictors of poor outcome after extra-corporeal membrane oxygenation for refractory cardiac arrest (ECPR): a post hoc analysis of a multicenter database.","volume":"170","author":"Halenarova","year":"2022","journal-title":"Resuscitation."},{"key":"B16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.resuscitation.2016.07.237","article-title":"Practice characteristics of emergency department extracorporeal cardiopulmonary resuscitation (ECPR) programs in the united states: the current state of the art of emergency department extracorporeal membrane oxygenation (ED ECMO).","volume":"107","author":"Tonna","year":"2016","journal-title":"Resuscitation."},{"key":"B17","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jtcvs.2021.06.024","article-title":"Clinical efficacy of direct or indirect left ventricular unloading during venoarterial extracorporeal membrane oxygenation for primary cardiogenic shock.","volume":"165","author":"Char","year":"2021","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MAT.0000000000000789","article-title":"Left ventricular distension in veno-arterial extracorporeal membrane oxygenation: from mechanics to therapies.","volume":"65","author":"Rajagopal","year":"2019","journal-title":"ASAIO J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/0267659118794112","article-title":"Left ventricular unloading during veno-arterial ECMO: a review of percutaneous and surgical unloading interventions.","volume":"34","author":"Donker","year":"2019","journal-title":"Perfusion."},{"key":"B20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.xjtc.2022.02.039","article-title":"Extracorporeal membrane oxygenation and left ventricular unloading: what is the evidence?","volume":"13","author":"Lorusso","year":"2022","journal-title":"JTCVS Tech."},{"key":"B21","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/MAT.0b013e3181b899c0","article-title":"Postcardiotomy extracorporeal life support in adults: the optimal duration of bridging to recovery.","volume":"55","author":"Wu","year":"2009","journal-title":"ASAIO J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/SHK.0000000000001220","article-title":"Predictors of successful weaning from veno-arterial extracorporeal membrane oxygenation after coronary revascularization for acute myocardial infarction complicated by cardiac arrest: a retrospective multicenter study.","volume":"51","author":"Sugiura","year":"2019","journal-title":"Shock."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jcin.2021.03.048","article-title":"Association between timing of extracorporeal membrane oxygenation and clinical outcomes in refractory cardiogenic shock.","volume":"14","author":"Lee","year":"2021","journal-title":"JACC Cardiovasc Interv."},{"key":"B24","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0735-1097(03)00648-X","article-title":"Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults.","volume":"42","author":"Bowles","year":"2003","journal-title":"J Am Coll Cardiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1093\/eurheartj\/ehm076","article-title":"A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis.","volume":"28","author":"Caforio","year":"2007","journal-title":"Eur Heart J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1093\/eurheartj\/ehr165","article-title":"The management of myocarditis.","volume":"32","author":"Schultheiss","year":"2011","journal-title":"Eur Heart J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/01.CIR.99.8.1091","article-title":"From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.","volume":"99","author":"Kawai","year":"1999","journal-title":"Circulation."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004471.pub3","article-title":"Corticosteroids for viral myocarditis.","volume":"2013","author":"Chen","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s00380-013-0368-4","article-title":"Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance.","volume":"29","author":"Kishimoto","year":"2014","journal-title":"Heart Vessels."},{"key":"B30","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1172\/JCI112835","article-title":"Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin.","volume":"79","author":"Leung","year":"1987","journal-title":"J Clin Invest."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa190","article-title":"Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin.","volume":"42","author":"Hu","year":"2021","journal-title":"Eur Heart J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1536\/ihj.18-299","article-title":"Intravenous immunoglobulin therapy for acute myocarditis in children and adults.","volume":"60","author":"Huang","year":"2019","journal-title":"Int Heart J."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1146570\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T04:53:43Z","timestamp":1678942423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1146570\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":32,"alternative-id":["10.3389\/fmed.2023.1146570"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1146570","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"article-number":"1146570"}}